Inhibition of neuroactive ligand-receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study.

Yang, Yun; Li, Jun; Jing, Chao; Zhai, Yuhao; Bai, Zhigang; Yang, Yingchi; Deng, Wei

Yang, Yun; Li, Jun; Jing, Chao; Zhai, Yuhao; Bai, Zhigang; Yang, Yingchi; Deng, Wei.

Affiliation

Yang Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Li J; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jing C; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhai Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Bai Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Yang Y; Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Beijing, China.
Deng W; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Expert Rev Anticancer Ther ; 23(11): 1205-1215, 2023.

Article in En | MEDLINE | ID: mdl-37555253

Subject(s)

Adenocarcinoma; Colonic Neoplasms; Humans; Colonic Neoplasms/genetics; Colonic Neoplasms/therapy; Ligands; Immunotherapy; Databases, Factual; Prognosis

Key words

Homologous recombination deficiency; colon adenocarcinoma; immunoregulation; immunotherapy response; the neuroactive ligandreceptor interaction pathway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Colonic Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google